Clene (CLNN) Competitors $3.94 -0.02 (-0.38%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$3.94 0.00 (0.00%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLNN vs. CGEN, MOLN, ACOG, INMB, KYTX, ACTU, ALEC, LYEL, LXEO, and FATEShould you be buying Clene stock or one of its competitors? The main competitors of Clene include Compugen (CGEN), Molecular Partners (MOLN), Alpha Cognition (ACOG), INmune Bio (INMB), Kyverna Therapeutics (KYTX), Actuate Therapeutics (ACTU), Alector (ALEC), Lyell Immunopharma (LYEL), Lexeo Therapeutics (LXEO), and Fate Therapeutics (FATE). These companies are all part of the "pharmaceutical products" industry. Clene vs. Its Competitors Compugen Molecular Partners Alpha Cognition INmune Bio Kyverna Therapeutics Actuate Therapeutics Alector Lyell Immunopharma Lexeo Therapeutics Fate Therapeutics Compugen (NASDAQ:CGEN) and Clene (NASDAQ:CLNN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability. Does the media prefer CGEN or CLNN? In the previous week, Clene had 3 more articles in the media than Compugen. MarketBeat recorded 3 mentions for Clene and 0 mentions for Compugen. Compugen's average media sentiment score of 0.00 equaled Clene'saverage media sentiment score. Company Overall Sentiment Compugen Neutral Clene Neutral Which has more risk & volatility, CGEN or CLNN? Compugen has a beta of 2.57, indicating that its share price is 157% more volatile than the S&P 500. Comparatively, Clene has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Which has stronger valuation & earnings, CGEN or CLNN? Compugen has higher revenue and earnings than Clene. Compugen is trading at a lower price-to-earnings ratio than Clene, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCompugen$27.86M5.70-$14.23M-$0.16-11.13Clene$340K103.93-$39.40M-$4.04-0.97 Do analysts prefer CGEN or CLNN? Compugen currently has a consensus target price of $4.00, suggesting a potential upside of 124.72%. Clene has a consensus target price of $40.00, suggesting a potential upside of 916.52%. Given Clene's stronger consensus rating and higher probable upside, analysts plainly believe Clene is more favorable than Compugen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Compugen 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Clene 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.17 Is CGEN or CLNN more profitable? Compugen has a net margin of -51.27% compared to Clene's net margin of -8,306.00%. Clene's return on equity of 0.00% beat Compugen's return on equity.Company Net Margins Return on Equity Return on Assets Compugen-51.27% -24.51% -12.19% Clene -8,306.00%N/A -105.11% Do institutionals & insiders believe in CGEN or CLNN? 12.2% of Compugen shares are held by institutional investors. Comparatively, 23.3% of Clene shares are held by institutional investors. 9.5% of Compugen shares are held by company insiders. Comparatively, 35.3% of Clene shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryClene beats Compugen on 10 of the 16 factors compared between the two stocks. Get Clene News Delivered to You Automatically Sign up to receive the latest news and ratings for CLNN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLNN vs. The Competition Export to ExcelMetricCleneMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$35.48M$2.91B$5.53B$8.95BDividend YieldN/A2.42%5.38%4.08%P/E Ratio-0.9721.5627.4020.24Price / Sales103.93274.65418.19125.29Price / CashN/A41.9536.6357.47Price / Book-3.717.518.085.67Net Income-$39.40M-$55.05M$3.16B$248.47M7 Day Performance4.65%4.59%2.81%3.29%1 Month Performance-2.11%4.86%3.69%5.18%1 Year Performance-39.91%5.82%35.30%21.35% Clene Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLNNClene2.3144 of 5 stars$3.94-0.4%$40.00+916.5%-39.9%$35.48M$340K-0.97100CGENCompugen1.5691 of 5 stars$1.63-0.6%$4.00+145.4%+6.6%$145.46M$27.86M-10.1970MOLNMolecular Partners2.9976 of 5 stars$3.58-8.0%$12.00+235.2%-43.8%$144.56M$5.65M-1.86180ACOGAlpha Cognition1.7579 of 5 stars$9.00-1.7%$20.00+122.2%N/A$144.18MN/A-7.50N/ANews CoveragePositive NewsINMBINmune Bio1.6236 of 5 stars$6.22-2.5%$22.80+266.6%-67.4%$142.94M$10K-3.2210Trending NewsAnalyst ForecastGap DownHigh Trading VolumeKYTXKyverna Therapeutics1.7511 of 5 stars$3.22+4.9%$18.50+474.5%-62.3%$139.17M$7.03M-0.9596ACTUActuate Therapeutics2.9889 of 5 stars$7.05-5.6%$20.50+190.8%N/A$138.32MN/A0.0010ALECAlector3.6487 of 5 stars$1.38-6.5%$4.00+190.9%-66.6%$137.49M$100.56M-1.09270LYELLyell Immunopharma2.7894 of 5 stars$8.99+3.5%$20.00+122.5%-68.8%$133.14M$60K-0.36270LXEOLexeo Therapeutics1.9309 of 5 stars$3.96+1.3%$16.60+319.2%-70.2%$131.46M$650K-1.2058FATEFate Therapeutics4.0658 of 5 stars$1.14-4.2%$3.83+236.3%-63.8%$130.64M$13.63M-0.77550News Coverage Related Companies and Tools Related Companies CGEN Competitors MOLN Competitors ACOG Competitors INMB Competitors KYTX Competitors ACTU Competitors ALEC Competitors LYEL Competitors LXEO Competitors FATE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLNN) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLNN Stock Alerts